Patent Assignment
Reel/Frame 051586/0274
Assignment of Assignor's Interest
Recorded: 2020-01-14
Pages: 45
Assignor
UBIOME, INC.
Executed: 2019-12-27
Assignee
PSOMAGEN, INC.
1330 PICCARD DR, ROCKVILLE, MARYLAND, 20850
Covered Properties
(267)
Method and System for Microbiome Analysis
Method and System for Microbiome Analysis
Method and System for Microbiome Analysis
Method and System for Microbiome-Derived Diagnostics and Therapeutics
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Neurological Health Issues
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Automimmune System Conditions
Method and System for Microbiome-Derived Characterization, Diagnostics and Therapeutics for Cardiovascular Disease Conditions
Method and System for Microbiome-Derived Characterization, Diagnostics and Therapeutics for Conditions Associated with Functional Features
Method and System for Microbiome-Derived Characterization, Diagnostics and Therapeutics for Cutaneous Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Conditions Associated with Microbiome Taxonomic Features
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Conditions Associated with Microbiome Functional Features
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Locomotor System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Mental Health Associated Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Endocrine System Conditions
Method and System for Sequencing in Characterization of Antibody Binding Behavior
Application:
15/183,643 →
Publication:
US 2016/0362738
Method and System for Sequencing in Characterization of Antibody Binding Behavior
Application:
15/183,652 →
Publication:
US 2016/0362742
Method and System for Diagnostic Testing
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Neurological Health Issues
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Autoimmune System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Endocrine System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Endocrine System Conditions
Manipulation of Sample Droplets with an Electrode System
Method and System for Multiplex Primer Design
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Neurological Health Issues
Application:
15/294,482 →
Publication:
US 2017/0039347
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Conditions Associated with Microbiome Taxonomic Features
Application:
15/294,526 →
Publication:
US 2017/0035346
Method and System for Characterization of Clostridium Difficile Associated Conditions
Application:
15/374,890 →
Publication:
US 2017/0235902
Method and System for Characterizing Mouth-Associated Conditions
Method and System for Characterizing Skin Related Conditions
Method and System for Microbiome Analysis
Method and System for Microbiome Analysis
Method and System for Microbiome-Derived Diagnostics and Therapeutics
Method and System for Microbiome-Derived Diagnostics and Therapeutics
Method and System for Microbiome-Derived Diagnostics and Therapeutics
Method and System for Microbiome-Derived Diagnostics and Therapeutics
Method and System for Microbiome-Derived Diagnostics and Therapeutics
Method and System for Microbiome-Derived Diagnostics and Therapeutics
Method and System for Microbiome-Derived Diagnostics and Therapeutics
Method and System for Microbiome-Derived Diagnostics and Therapeutics
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Neurological Health Issues
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Neurological Health Issues
Application:
15/621,187 →
Publication:
US 2017/0277844
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Neurological Health Issues
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Neurological Health Issues
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Neurological Health Issues
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Neurological Health Issues
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Neurological Health Issues
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Conditions Associated with Microbiome Functional Features
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Autoimmune System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Autoimmune System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Autoimmune System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Autoimmune System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Autoimmune System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Autoimmune System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Autoimmune System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Autoimmune System Conditions
Method and System for Microbial Pharmacogenomics
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Endocrine System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Endocrine System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Endocrine System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Endocrine System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Endocrine System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Endocrine System Conditions
Method and System for Microbiome-Derived Characterization, Diagnostics, and Therapeutics for Cardiovascular Disease Conditions
Application:
15/664,067 →
Publication:
US 2017/0329923
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Mental Health Associated Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Mental Health Associated Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Mental Health Associated Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Mental Health Associated Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Locomotor System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Locomotor System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Locomotor System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Locomotor System Conditions
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Conditions Associated with Microbiome Functional Features
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Conditions Associated with Microbiome Taxonomic Features
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Conditions Associated with Microbiome Taxonomic Features
Method and System for Panel Characterizations
Method and System for Crispr-Based Library Preparation and Sequencing
Method and System for Fragment Assembly and Sequence Identification
Method and System for Microbiome-Derived Characterization, Diagnostics and Therapeutics for Conditions Associated with Functional Features
Method and System for Microbiome-Derived Characterization, Diagnostics and Therapeutics for Conditions Associated with Functional Features
Method and System for Microbiome-Derived Characterization, Diagnostics and Therapeutics for Conditions Associated with Functional Features
Method and System for Microbiome-Derived Characterization, Diagnostics, and Therapeutics for Cardiovascular Disease Conditions
Method and System for Microbiome-Derived Characterization, Diagnostics, and Therapeutics for Cardiovascular Disease Conditions
Method and System for Characterizing a Headache-Related Condition
Method and System for Characterizing Diet-Related Conditions
Method and System for Characterizing Allergy-Related Conditions Associated with Microorganisms
Method and System for Characterizing Microorganism-Related Conditions
Method and System for Microbiome-Derived Characterization, Diagnostics, and Therapeutics for Cardiovascular Disease Conditions
Method and System for Microbiome-Derived Characterization, Diagnostics, and Therapeutics for Cardiovascular Disease Conditions
Method and System for Microbiome-Derived Characterization, Diagnostics and Therapeutics for Cutaneous Conditions
Method and System for Microbiome-Derived Characterization, Diagnostics and Therapeutics for Cutaneous Conditions
Method and System for Microbiome-Derived Characterization, Diagnostics and Therapeutics for Cutaneous Conditions
Method and System for Microbiome-Derived Characterization, Diagnostics and Therapeutics for Cutaneous Conditions
Therapeutic & Diagnostics Compositions Targeting Toll-Like Receptors and Methods Thereof
Method and System for Characterizing Microorganism-Associated Sleep-Related Conditions
Method and System for Library Preparation with Unique Molecular Identifiers
Application:
16/013,858 →
Publication:
US 2018/0362967
Method and System for Characterization for Appendix-Related Conditions Associated with Microorganisms
Application:
16/039,276 →
Publication:
US 2018/0342322
Disease-Associated Microbiome Characterization Process
Application:
16/047,840 →
Publication:
US 2019/0050534
Method and System for Microbiome-Derived Diagnostics and Therapeutics Infectious Disease and Other Health Conditions Associated with Antibiotic Usage
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Bacterial Vaginosis
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Conditions Associated with Gastrointestinal Health
Application:
16/084,946 →
Publication:
US 2019/0085396
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Oral Health
Application:
16/084,947 →
Publication:
US 2019/0172555
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Conditions Associated with Thyroid Health Issues
Application:
16/084,962 →
Publication:
US 2019/0087536
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Eczema
Application:
16/084,964 →
Publication:
US 2019/0136298
Method and System for Microbiome-Derived Diagnostics and Therapeutics for Cerebro-Craniofacial Health
Application:
16/084,965 →
Publication:
US 2019/0211378
Rieske-Type Oxygenase/Reductase Targeted Drugs for Diagnostic and Treatment of Diseases
Application:
16/103,830 →
Publication:
US 2019/0050525
Device for Protecting and Sealing the Opening of a Container
Application:
16/115,536 →
Publication:
US 2019/0062010
Method and System for Characterization for Female Reproductive System-Related Conditions Associated with Microorganisms
Nasal-Related Characterization Associated with the Nose Microbiome
Application:
16/124,108 →
Publication:
US 2019/0019575
Normalization for Sequencing Libraries
Application:
16/125,619 →
Publication:
US 2019/0078085
Microorganism-Related Significance Index Metrics
Application:
16/132,195 →
Publication:
US 2019/0080046
Single Molecule Sequencing and Unique Molecular Identifiers to Characterize Nucleic Acid Sequences
Application:
16/155,729 →
Publication:
US 2019/0136310
Control Processes for Microorganism-Related Characterization Processes
Application:
16/182,482 →
Publication:
US 2019/0136288
Method and System for Fragment Assembly and Sequence Identification
Application:
16/376,355 →
Publication:
US 2019/0237159
Plasmid Controls
Application:
61/931,612 →
Multiplex Markers
Application:
61/953,683 →
Microbiome Analysis
Application:
62/024,947 →
System and Method for Microbiome Analysis and Adjustment
Application:
62/066,369 →
Method and System for Microbiome-Derived Diagnostics and Therapeutics
Application:
62/087,551 →
Method and System for Characterizing Reflux Diseases
Application:
62/146,767 →
Method and System for Characterizing Acne
Application:
62/146,789 →
Method and System for Characterizing Attention Deficit Disorders
Application:
62/146,810 →
Method and System for Characterizing Acquired Immune Deficiency Syndrome
Application:
62/146,818 →
Method and System for Characterizing Anxiety
Application:
62/146,833 →
Method and System for Characterizing Asthma
Application:
62/146,846 →
Method and System for Characterizing Autism
Application:
62/146,852 →
Method and System for Characterizing Chronic Fatigue Syndrome
Application:
62/147,058 →
Method and System for Characterizing Colorectal Cancer
Application:
62/147,071 →
Method and System for Characterizing Depression
Application:
62/147,077 →
Method and System for Characterizing Dermatomyositis
Application:
62/147,083 →
Method and System for Characterizing Coronary Heart Disease
Application:
62/147,092 →
Method and System for Characterizing Gastric Cancer
Application:
62/147,096 →
Method and System for Characterizing Gout
Application:
62/147,102 →
Method and System for Characterizing Graves Disease
Application:
62/147,107 →
Method and System for Characterizing Aspergers Syndrome
Application:
62/147,124 →
Method and System for Characterizing Hashimotos Thyroiditis
Application:
62/147,202 →
Method and System for Characterizing Inflammatory Heart Disease
Application:
62/147,217 →
Method and System for Characterizing Metabolic Disease
Application:
62/147,226 →
Method and System for Characterizing Multiple Sclerosis
Application:
62/147,287 →
Method and System for Characterizing Obesity
Application:
62/147,304 →
Method and System for Characterizing Parkinsons Disease
Application:
62/147,314 →
Method and System for Characterizing Pernicious Anemia
Application:
62/147,315 →
Method and System for Characterizing Reactive Arthritis
Application:
62/147,321 →
Method and System for Characterizing Rheumatoid Arthritis
Application:
62/147,324 →
Method and System for Characterizing Sjogrens Syndrome
Application:
62/147,328 →
Method and System for Characterizing Sprue
Application:
62/147,334 →
Method and System for Characterizing Stroke
Application:
62/147,337 →
Method and System for Characterizing Systemic Lupus Erythematosus
Application:
62/147,345 →
Method and System for Characterizing Type I Diabetes
Application:
62/147,348 →
Method and System for Characterizing Type Ii Diabetes
Application:
62/147,355 →
Method and System for Characterizing Valvular Heart Disease
Application:
62/147,364 →
Method and System for Nucleic Acid Sequencing in Characterization of Antibody Binding Behavior
Application:
62/175,748 →
Method and System for Diagnostic Testing
Application:
62/186,793 →
Igital Microfluidics System and Method
Application:
62/201,001 →
Method and System for Multiplex Primer Design
Application:
62/206,654 →
Digital Microfluidics System and Method
Application:
62/212,998 →
Method and System for Characterizing Antibiotic Usage
Application:
62/215,891 →
Method and System for Characterizing Bloody Stool
Application:
62/215,892 →
Method and System for Characterizing Constipation
Application:
62/215,900 →
Method and System for Characterizing Dental Decay
Application:
62/215,909 →
Method and System for Characterizing Diarrhea
Application:
62/215,912 →
Method and System for Characterizing Eczema
Application:
62/215,917 →
Method and System for Characterizing Gingivitis
Application:
62/215,924 →
Method and System for Characterizing Headaches
Application:
62/215,939 →
Method and System for Characterizing Hyperthyroidism
Application:
62/216,002 →
Method and System for Characterizing Insomnia
Application:
62/216,016 →
Method and System for Characterizing Lactose Intolerance
Application:
62/216,023 →
Method and System for Characterizing Light Sleep
Application:
62/216,028 →
Method and System for Characterizing Poor Concentration
Application:
62/216,035 →
Method and System for Characterizing Sinusitis
Application:
62/216,042 →
Method and System for Characterizing Stomach Gas and Bloating
Application:
62/216,049 →
Method and System for Characterizing Bacterial Vaginosis
Application:
62/216,082 →
Method and System for Characterizing Hemorrhoids
Application:
62/216,086 →
Method and System for Characterization of Clostridium Difficile-Associated Conditions
Application:
62/265,077 →
Method and System for Characterizing Gingivitis
Application:
62/304,642 →
Method and System for Characterizing Halitosis
Application:
62/304,645 →
Method and System for Characterizing Dry Skin
Application:
62/327,048 →
Method and System for Characterizing Dandruff
Application:
62/327,089 →
Method and System for Characterizing Photosensitivity
Application:
62/327,126 →
Method and System for Microbial Pharmacogenomics
Application:
62/361,943 →
Method and System for Gut Pathogen Panel Characterizations
Application:
62/395,939 →
Method and System for Crispr-Based Library Preparation and Sequencing
Application:
62/400,401 →
Method and System for Fragment Assembly and Sequence Identification
Application:
62/420,733 →
Method and System for Characterizing Migraine
Application:
62/424,717 →
Method and System for Fragment Assembly and Sequence Identification
Application:
62/424,843 →
Method and System for Characterizing Wheat Allergy Microorganisms-Associated
Application:
62/434,881 →
Method and System for Characterizing Treenut Allergy-Associated-Microorganisms
Application:
62/434,894 →
Method and System for Characterizing Shellfish Allergy-Associated-Microorganisms
Application:
62/434,902 →
Method and System for Characterizing Soy Allergy-Associated-Microorganisms
Application:
62/434,912 →
Method and System for Characterizing Peanut Allergy-Associated-Microorganisms
Application:
62/434,917 →
Method and System for Characterizing Egg Allergy-Associated-Microorganisms with Food Habits and Diet
Application:
62/434,923 →
Method and System for Characterizing Associated-Microorganisms for Two Diet Sets: Vegetarian & Vegan Diet Vs Omnivores & Raw Meat Eaters
Application:
62/434,948 →
Method and System for Characterizing Associated-Microorganisms for Two Diet Sets: Lowcarb Diet Vs Omnivores & Raw Meat Eaters
Application:
62/434,952 →
Method and System for Characterizing Associated-Microorganisms for Two Diet Sets: Lowcarb Diet Vs Vegetarians & Vegans
Application:
62/434,959 →
Method and System for Characterizing Associated-Microorganisms for Two Diet Sets: Dairy Free & Gluten Free Diet Vs Omnivores
Application:
62/434,978 →
Method and System for Characterizing Associated-Microorganisms for Two Diet Sets: Dairy Free & Gluten Free Diet Vs Vegetarian
Application:
62/434,995 →
Method and System for Characterizing Diabetes-Associated-Microorganisms with Food Habits & Diet
Application:
62/434,999 →
Method and System for Characterizing Lactose & Fermented Food Tolerance Associated-Microorganisms
Application:
62/435,006 →
Method and System for Characterizing Microorganism-Associated Dairy Allergies
Application:
62/435,013 →
Method and System for Characterizing Caffeine Consumption Associated-Microorganisms
Application:
62/435,167 →
Method and System for Characterizing Cancer-Associated-Microorganisms
Application:
62/435,170 →
Method and System for Characterizing Anemia-Associated-Microorganisms
Application:
62/435,178 →
Method and System for Characterizing Alcohol Consumption Associated-Microorganisms
Application:
62/435,184 →
Method and System for Characterizing Extreme Physical Exercises Associated-Microorganisms
Application:
62/435,246 →
Method and System for Characterizing Moderate Physical Exercises Associated-Microorganisms
Application:
62/435,263 →
Method and System for Characterizing Menopause Associated-Microorganisms
Application:
62/435,299 →
Method and System for Characterizing Probiotics-Associated-Microorganisms with Food Habits an Diet
Application:
62/435,316 →
Method and System for Characterizing Lyme Disease-Associated-Microorganisms
Application:
62/435,332 →
Therapeutic & Diagnostics Compositions Targeting Toll-Like Receptors and Methods Thereof
Application:
62/468,286 →
Method and System for Characterizing Microorganism-Associated Sleep Quality
Application:
62/514,356 →
Method and System for Characterizing Sleep Quality Microorganism-Associated
Application:
62/515,396 →
Method and System for Panel Characterizations
Application:
62/520,058 →
Unique Molecular Identifiers in Library Preparation for Ngs
Application:
62/522,293 →
Method and System for Evaluating Microbiome Characteristics
Application:
62/525,379 →
Method and System for Characterizing Microorganisms-Associated Appendix Conditions Diagnosis and Treatment
Application:
62/533,816 →
Therapeutic & Diagnostics Compositions Targeting Toll-Like Receptors and Methods Thereof
Application:
62/536,924 →
Method and System for Characterizing Skin Related Conditions
Application:
62/545,039 →
Choline Lyase Enzyme Targeted Drugs for Diagnostic and Treatment of Diseases
Application:
62/545,056 →
Rieske-Type Oxygenase/Reductase Targeted Drugs for Diagnostic and Treatment of Diseases
Application:
62/545,065 →
Method and System for Vaginal Panel Characterizations
Application:
62/551,155 →
Flask Plug
Application:
62/551,157 →
Signature of the Nose Microbiome Across Geographical and Temporal Changes
Application:
62/554,985 →
Three Step Pcr for Normalized Library Preparation for Next Generation Sequencing
Application:
62/555,782 →
Method and System for Characterizing Cluster 1 Allergy-Associated-Microorganisms: Wheat Allergy and Egg Allergy
Application:
62/557,423 →
Method to Calculate an Association Significance Index Between Health Condition and Taxa
Application:
62/558,489 →
Method and System for Characterizing Cluster 2 Allergy-Associated-Microorganisms: Treenut Allergy, Peanut Allergy, Shellfish Allergy and Soy Allergy
Application:
62/564,777 →
Single Molecule Sequencing and Unique Molecular Identifiers to Characterize Nucleic Acid Sequences
Application:
62/569,853 →
Precision Sequencing Method and System
Application:
62/582,162 →
Microbiome Profile Metrics Based on the Inclusion of Replicates of Biological Control Samples
Application:
62/582,172 →
Disease-Associated Microbiome Characterisation Process
Application:
62/582,191 →
Sequencing-Based Women's Health Assay Combining Self-Sampling, Hpv Detection and Genotyping, Sti Detection, and Vaginal Microbiome Analysis
Application:
62/585,131 →
High-Throughput Particle Handling Through Direct Interaction to a Dimensional Space Driver, by Use of Magnetic Fields
Application:
62/637,959 →
Machine Learning and Artificial Intelligence Applications for Precision Medicine Solutions
Application:
62/644,347 →
Magnetic Field-Based Nucleic Acid Manipulation and/or Extraction
Application:
62/645,091 →
Novel Sequencing-Based Women's Health Assay Combining Self-Sampling, Hpv Detection and Genotyping, Sti Detection, and Vaginal Microbiome Analysis
Application:
62/653,402 →
Cross-phenotype correlations reveal role of microbiome on disease pleiotropy
Application:
62/658,308 →
Normalization method by using magnetic fields and device
Application:
62/671,410 →
Measures of reproducibility in sampling and laboratory processing methods in high-throughput microbiome analysis
Application:
62/671,435 →
Metabolism Predictor Tool
Application:
62/679,783 →
Metabolism Explorer
Application:
62/679,785 →
Vitamins Explorer
Application:
62/679,787 →
Artificial Sweeteners Explorer
Application:
62/724,928 →
Xenobiotics Metabolism
Application:
62/737,108 →
Alcohol Explorer
Application:
62/759,975 →
Alcohol Metabolism Explorer
Application:
62/770,919 →
Automatic standardization pipeline for data analysis
Application:
62/780,759 →
Small molecules as Inhibitors of HpHtRA protein in Helicobacter pylori
Application:
62/788,939 →
CagA inhibitors associated with the H. pylori and/or gastric cancer
Application:
62/788,953 →
Method and System to Target Bacteria with Antibacterial Compounds from the Microbiota
Application:
62/788,955 →
Method and System for Protecting Cell Junctions Proteins of Intestinal Epithelium
Application:
62/788,957 →
Method and System for Targeting Microbiota Proteins Mimicking Host Proteins
Application:
62/788,958 →
Beyond nucleic acid detection: DNA-LISA
Application:
62/797,165 →
Epitope-Based Approach for a HPV6 Treatment and Detection Method, System, and Therapeutic Compositions
Application:
62/797,167 →
Epitope-Based Approach for a HPV11 Treatment and Detection Method, System, and Therapeutic Compositions
Application:
62/797,171 →
Epitope-Based Approach for a HPV16 Treatment and Detection Method, System, and Therapeutic Compositions
Application:
62/797,173 →
Epitope-Based Approach for a HPV18 Treatment and Detection Method, System, and Therapeutic Compositions
Application:
62/797,175 →
TMA Explorer
Application:
62/799,294 →
Systems and Methods for Microbiome Modulation
Application:
62/807,760 →
Improved Methods and System for Diagnostics and/or Treatment for Cancer-Related Conditions associated with HPV infection
Application:
62/807,761 →
Method and system for microbiome-derived companion diagnostics
Application:
62/808,304 →
Epitope-based approach for virulence factors and/or food allergy treatments and detection methods, systems, and/or therapeutics compositions
Application:
62/817,564 →
Epitope-based approach as a detection and/or treatment method, system, and/or therapeutic composition for peanuts allergy and/or related dietary food
Application:
62/817,621 →
Unlocking the Microbiome for New Opportunities in Drug Discovery
Application:
62/824,095 →
Antibacterial Compounds Platform
Application:
62/826,479 →
Platform for selection of microorganisms for phage for treatment of conditions
Application:
62/826,497 →
Platform for selection of microorganisms for Live Biotherapeutics (LBPs) for treatment of conditions
Application:
62/826,505 →
Bacterial Metabolites Inhibitors Platform
Application:
62/826,515 →
Design of inhibitors of Crohn's Disease-Associated I2 Superantigen and MHC-II
Application:
62/828,074 →
Unlocking the Microbiome for New Opportunities in Drug Discovery
Application:
62/832,811 →
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 9, 2015
From: APTE, ZACHARY; RICHMAN, JESSICA
To: UBIOME, INC.
Reel/Frame 034674/0722 →
Assignment of Assignor's Interest
Jan 9, 2015
From: APTE, ZACHARY; RICHMAN, JESSICA
To: UBIOME, INC.
Reel/Frame 034674/0578 →
Assignment of Assignor's Interest
Jan 9, 2015
From: APTE, ZACHARY; RICHMAN, JESSICA
To: UBIOME, INC.
Reel/Frame 034674/0423 →
Assignment of Assignor's Interest
Nov 18, 2015
From: APTE, ZACHARY; RICHMAN, JESSICA; BELBAHANI, SIAVOSH REZVAN; ALMONACID, DANIEL
To: UBIOME, INC.
Reel/Frame 037070/0580 →
Assignment of Assignor's Interest
Apr 26, 2016
From: ALMONACID, DANIEL; APTE, ZACHARY; RICHMAN, JESSICA; BEHBAHANI, SIAVOSH REZVAN
To: UBIOME, INC.
Reel/Frame 038382/0976 →
Assignment of Assignor's Interest
Apr 26, 2016
From: ALMONACID, DANIEL; APTE, ZACHARY; RICHMAN, JESSICA; BEHBAHANI, SIAVOSH REZVAN
To: UBIOME, INC.
Reel/Frame 038383/0776 →
Assignment of Assignor's Interest
Apr 26, 2016
From: ALMONACID, DANIEL; APTE, ZACHARY; RICHMAN, JESSICA; BEHBAHANI, SIAVOSH REZVAN
To: UBIOME, INC.
Reel/Frame 038384/0399 →
Assignment of Assignor's Interest
Apr 26, 2016
From: ALMONACID, DANIEL; APTE, ZACHARY; RICHMAN, JESSICA; BEHBAHANI, SIAVOSH REZVAN
To: UBIOME, INC.
Reel/Frame 038384/0595 →
Assignment of Assignor's Interest
Apr 26, 2016
From: ALMONACID, DANIEL; APTE, ZACHARY; RICHMAN, JESSICA; BEHBAHANI, SIAVOSH REZVAN
To: UBIOME, INC.
Reel/Frame 038385/0146 →
Assignment of Assignor's Interest
Apr 26, 2016
From: ALMONACID, DANIEL; APTE, ZACHARY; RICHMAN, JESSICA; BEHBAHANI, SIAVOSH REZVAN
To: UBIOME, INC.
Reel/Frame 038384/0854 →
Assignment of Assignor's Interest
Apr 26, 2016
From: ALMONACID, DANIEL; APTE, ZACHARY; RICHMAN, JESSICA; BELBAHANI, SIAVOSH REZVAN
To: UBIOME, INC.
Reel/Frame 038382/0347 →
Assignment of Assignor's Interest
Apr 26, 2016
From: ALMONACID, DANIEL; APTE, ZACHARY; RICHMAN, JESSICA; BEHBAHANI, SIAVOSH REZVAN
To: UBIOME, INC.
Reel/Frame 038382/0506 →
Assignment of Assignor's Interest
Apr 26, 2016
From: ALMONACID, DANIEL; APTE, ZACHARY; RICHMAN, JESSICA; BEHBAHANI, SIAVOSH REZVAN
To: UBIOME, INC.
Reel/Frame 038382/0557 →
Assignment of Assignor's Interest
May 5, 2016
From: APTE, ZACHARY; ALMONACID, DANIEL; RICHMAN, JESSICA; BELBAHANI, SIAVOSH REZVAN
To: UBIOME, INC.
Reel/Frame 038481/0018 →
Assignment of Assignor's Interest
Jul 13, 2016
From: APTE, ZACHARY; ALMONACID, DANIEL; RICHMAN, JESSICA
To: UBIOME, INC.
Reel/Frame 039151/0079 →
Assignment of Assignor's Interest
Jul 27, 2016
From: APTE, ZACHARY; RICHMAN, JESSICA; ALMONACID, DANIEL
To: UBIOME, INC.
Reel/Frame 039272/0235 →
Assignment of Assignor's Interest
Sep 6, 2016
From: BEHBAHANI, SIAVOSH REZVAN; APTE, ZACHARY; RICHMAN, JESSICA; ALMONACID, DANIEL
To: UBIOME, INC.
Reel/Frame 039645/0038 →
Assignment of Assignor's Interest
Dec 8, 2016
From: APTE, ZACHARY; ALMONACID, DANIEL; RICHMAN, JESSICA
To: UBIOME, INC.
Reel/Frame 040606/0967 →